Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

European Patient Summary

Patient
Name: Baum, Lara
DOB: 10-DEC-1969 (Age: 56)
Gender: female
ID: 3227-921774-2 (ECI)
Author
Budig, Liesbeth
Patient summary Document
European Patient Summary
Report Date: 06-JUL-2025

Problem list

Condition Onset Date / Period Status
Osteoarthritis of knee 18-Mar-2025 active
Disorder of kidney due to diabetes mellitus 19-Nov-2023 active
Chronic kidney disease stage 1 19-Nov-2023 active
Metabolic syndrome X 16-Sep-2012 active
Essential hypertension 11-Jun-1995 active
Acute bronchitis 12-Mar-2023 - 25-Mar-2023 inactive
Partial thickness burn 14-Apr-2022 - 04-Jun-2022 inactive
Viral sinusitis 13-May-2020 - 23-May-2020 inactive
Laceration of thigh 04-Feb-2016 - 18-Feb-2016 inactive
Laceration - injury 04-Feb-2016 - 18-Feb-2016 inactive

Medication list

Medication Since Form Dosage Reason
Human isophane insulin 70 unit/mL and recombinant human regular insulin 30 unit/mL solution for injection 2025-07-06 - Inject 10 units (70/30 insulin) subcutaneously once daily before breakfast Prediabetes
Amlodipine (as amlodipine besylate) 2.5 mg oral tablet 2025-07-06 - 1 tablet (2.5 mg) by mouth once daily Essential hypertension (disorder)
Hydrochlorothiazide 25 mg oral tablet 2025-07-06 - 1 tablet (25 mg) by mouth once daily Essential hypertension (disorder)
Lisinopril 10 mg oral tablet 2025-07-06 - 1 tablet (10 mg) by mouth once daily Essential hypertension (disorder)
Naproxen sodium 220 mg oral capsule 2025-03-18 - 1 capsule (220 mg) every 12 hours as needed Osteoarthritis of knee
Vitamin B12 and/or vitamin B12 derivative-containing product 1987-06-07 - 1000 mcg once daily -

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 24-Nov-2024
SARS-CoV-2 mRNA vaccine 20-Jun-2021
Clostridium tetani toxoid antigen adsorbed only vaccine product 21-Oct-2018
Live attenuated Human alphaherpesvirus 3 only vaccine product 21-Oct-2018

Procedure History list

Procedure Date Reason
Depression screening 06-Jul-2025 -
Medication reconciliation 06-Jul-2025 -
Assessment of health and social care needs 06-Jul-2025 -
Assessment of anxiety 06-Jul-2025 -
Screening for domestic abuse 06-Jul-2025 -
Pre-discharge assessment 06-May-2022 -
Discharge from hospital 06-May-2022 -
Nursing care/supplementary surveillance 05-May-2022 -
Professional / ancillary services care 03-May-2022 -
Occupational therapy 02-May-2022 -
Physical therapy procedure 02-May-2022 -
Speech and language therapy regime 02-May-2022 -
History AND physical examination 14-Apr-2022 -
Initial patient assessment 14-Apr-2022 -
Development of individualized plan of care 14-Apr-2022 -
Suture open wound 04-Feb-2016 Laceration of thigh (disorder)

Allergies and Intolerances

No known allergies or intolerances

Care Plan

Active Planned Care / Goals Start Date Reason
Musculoskeletal care 18-Mar-2025 Osteoarthritis of knee (disorder)
  • Reduce knee pain severity to improve mobility and quality of life
  • Increase ability to perform daily activities such as walking and climbing stairs
  • Engage in at least 150 minutes of moderate-intensity physical activity per week
Diabetes self management plan 19-Aug-2007 Prediabetes (finding)
  • Maintain hemoglobin A1c below 6.5% through diabetes self-management.
  • Achieve and maintain a 5% reduction in body weight to reduce diabetes risk.
  • Maintain blood pressure below 130/80 mmHg as part of diabetes self-management.
  • Engage in at least 150 minutes of moderate-intensity physical activity per week.
Lifestyle education regarding hypertension 11-Jun-1995 Essential hypertension (disorder)
  • Patient will demonstrate understanding of lifestyle modifications to manage blood pressure, including diet, exercise, and medication adherence.

Vital Signs

Vital Signs 2025-07-06 2025-03-18
Body Height 165.8 cm -
Pain severity - 0-10 verbal numeric rating [Score] - Reported 4 {score} 6 {score}
Body Weight 76.9 kg -
Body mass index (BMI) [Ratio] 28 kg/m2 -
Heart rate 77 /min -
Respiratory rate 15 /min -
Blood pressure panel with all children optional 77 mm[Hg] -

Relevant diagnostic tests/laboratory data

Recent Lab Observations 06-JUL-2025 Reference Range Unit
Glucose [Mass/volume] in Serum or Plasma 65.1 65 - 99 mg/dL
Urea nitrogen [Mass/volume] in Serum or Plasma 15.7 7 - 20 mg/dL
Creatinine [Mass/volume] in Serum or Plasma 1.6 H 0.5 - 1.1 mg/dL
Calcium [Mass/volume] in Serum or Plasma 9.6 8.6 - 10.3 mg/dL
Sodium [Moles/volume] in Serum or Plasma 140.4 135 - 145 mmol/L
Potassium [Moles/volume] in Serum or Plasma 4.0 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Serum or Plasma 109.1 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Serum or Plasma 22.9 22 - 32 mmol/L
Appearance of Urine Cloudy urine
Odor of Urine Urine smell ammoniacal
Clarity of Urine Translucent
Color of Urine Brown color
Glucose [Mass/volume] in Urine by Test strip 1.9 H 0 - 0 mg/dL
Glucose [Presence] in Urine by Test strip Urine glucose test = ++
Bilirubin.total [Mass/volume] in Urine by Test strip 1.3 0 - 4 mg/dL
Bilirubin.total [Presence] in Urine by Test strip Finding of bilirubin in urine
Ketones [Mass/volume] in Urine by Test strip 7.1 H 0 - 4 mg/dL
Ketones [Presence] in Urine by Test strip Urine ketone test = trace
Specific gravity of Urine by Test strip 1.0 L 1.005 - 1.030 {nominal}
pH of Urine by Test strip 5.7 4.5 - 8.0 pH
Protein [Mass/volume] in Urine by Test strip 117.3 H 0 - 20 mg/dL
Protein [Presence] in Urine by Test strip Urine protein test = +
Nitrite [Presence] in Urine by Test strip Urine nitrite negative
Hemoglobin [Presence] in Urine by Test strip Urine blood test = negative
Leukocyte esterase [Presence] in Urine by Test strip Urine leukocyte test negative
Hemoglobin A1c/Hemoglobin.total in Blood 4.0 4.0 - 5.6 %
Glucose [Mass/volume] in Blood 65.1 L 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 15.7 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 0.9 0.5 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 9.6 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 140.4 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.0 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 109.1 H 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 22.9 22 - 29 mmol/L

Device Use

Device Date (since)
Walking frame (physical object) 18-Mar-2025
Blood glucose meter (physical object) 19-Aug-2007